These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9058341)

  • 21. Age-specific success rate for women undertaking their first assisted reproduction technology treatment using their own oocytes in Australia, 2002-2005.
    Wang YA; Healy D; Black D; Sullivan EA
    Hum Reprod; 2008 Jul; 23(7):1633-8. PubMed ID: 18441345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The cost of a successful delivery with in vitro fertilization.
    Neumann PJ; Gharib SD; Weinstein MC
    N Engl J Med; 1994 Jul; 331(4):239-43. PubMed ID: 8015571
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcome of in vitro fertilization in women 45 years and older who use autologous oocytes.
    Spandorfer SD; Bendikson K; Dragisic K; Schattman G; Davis OK; Rosenwaks Z
    Fertil Steril; 2007 Jan; 87(1):74-6. PubMed ID: 17197285
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assisted reproductive technologies in Canada: 2005 results from the Canadian Assisted Reproductive Technologies Register.
    Gunby J; Bissonnette F; Librach C; Cowan L;
    Fertil Steril; 2009 May; 91(5):1721-30. PubMed ID: 18423460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In-vitro fertilisation in women aged 40 years and above.
    Seng SW; Yeong CT; Loh SF; Sadhana N; Loh SK
    Singapore Med J; 2005 Mar; 46(3):132-6. PubMed ID: 15735878
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Success rates and cost of a live birth following fresh assisted reproduction treatment in women aged 45 years and older, Australia 2002-2004.
    Sullivan E; Wang Y; Chapman M; Chambers G
    Hum Reprod; 2008 Jul; 23(7):1639-43. PubMed ID: 18417497
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness of highly purified human menopausal gonadotropin vs. recombinant follicle-stimulating hormone in first-cycle in vitro fertilization-intracytoplasmic sperm injection patients.
    Hompes PG; Broekmans FJ; Hoozemans DA; Schats R;
    Fertil Steril; 2008 Jun; 89(6):1685-93. PubMed ID: 17681325
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Age differences between sexual partners in the United States.
    Darroch JE; Landry DJ; Oslak S
    Fam Plann Perspect; 1999; 31(4):160-7. PubMed ID: 10435214
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An elevated basal FSH reflects a quantitative rather than qualitative decline of the ovarian reserve.
    Abdalla H; Thum MY
    Hum Reprod; 2004 Apr; 19(4):893-8. PubMed ID: 15016786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical effects of oocyte cryopreservation in assisted reproduction technology].
    Wang W; Yan ZJ; Cai LB; Chai DC; Liu CZ; Mao YD; Liu JY
    Zhonghua Yi Xue Za Zhi; 2008 Oct; 88(39):2755-8. PubMed ID: 19080449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Assisted reproductive techniques in women aged 38 years or more].
    Lamarche C; Lévy R; Felloni B; de Mouzon J; Denis-Belicard E; Huss M; Maubon I; Aknin I; Seffert P
    Gynecol Obstet Fertil; 2007 May; 35(5):420-9. PubMed ID: 17459756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expectation of pregnancy outcome among mature women.
    Porreco RP; Harden L; Gambotto M; Shapiro H
    Am J Obstet Gynecol; 2005 Jan; 192(1):38-41. PubMed ID: 15672000
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GnRH agonist. Increasing the pregnancy rate after combined treatment with hMG/hCG and direct intraperitoneal insemination.
    Minoura H; Takeuchi S; Shen X; Shibahara T; Futamura N; Toyoda N
    J Reprod Med; 1999 Jan; 44(1):18-22. PubMed ID: 9987734
    [TBL] [Abstract][Full Text] [Related]  

  • 34. One last chance for pregnancy: a review of 2,705 in vitro fertilization cycles initiated in women age 40 years and above.
    Klipstein S; Regan M; Ryley DA; Goldman MB; Alper MM; Reindollar RH
    Fertil Steril; 2005 Aug; 84(2):435-45. PubMed ID: 16084887
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro fertilization (IVF) versus gonadotropins followed by IVF as treatment for primary infertility: a cost-based decision analysis.
    Kansal-Kalra S; Milad MP; Grobman WA
    Fertil Steril; 2005 Sep; 84(3):600-4. PubMed ID: 16169391
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assisted reproductive technologies (ART) in Canada: 2003 results from the Canadian ART Register.
    Gunby J; Daya S;
    Fertil Steril; 2007 Sep; 88(3):550-9. PubMed ID: 17303133
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficiency of oocyte cryopreservation: a meta-analysis.
    Oktay K; Cil AP; Bang H
    Fertil Steril; 2006 Jul; 86(1):70-80. PubMed ID: 16818031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral ovulation induction agents combined with low-dose gonadotropin injections and intrauterine insemination: cost- and clinical effectiveness.
    Ryan GL; Moss V; Davis WA; Sparks AE; Dokras A; Van Voorhis BJ
    J Reprod Med; 2005 Dec; 50(12):943-50. PubMed ID: 16444896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes of pregnancies achieved by donor egg in vitro fertilization--a comparison with standard in vitro fertilization pregnancies.
    Wiggins DA; Main E
    Am J Obstet Gynecol; 2005 Jun; 192(6):2002-6; discussion 2006-8. PubMed ID: 15970875
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Fertility treatments: possibilities for fewer multiple births and lower costs--the 'Umbrella' study].
    Merkus JM
    Ned Tijdschr Geneeskd; 2006 May; 150(21):1162-4. PubMed ID: 16768277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.